Who are Lifecore Biomedical, Inc.'s main suppliers?

Lifecore Biomedical, Inc. (LFCR) key suppliers include: Alcon Inc., Semnur Pharmaceuticals, Inc.. View the full supplier network at chainsifter.com/chain/LFCR.

Who are Lifecore Biomedical, Inc.'s major customers?

Lifecore Biomedical, Inc. (LFCR) key customers include: ALCON, ALCON-RESEARCH-LLC, COMPANY-CAMDEN-FRUIT-CORP, CURATION-FOODS-INC, FILO-AMENDMENT-LIMITED and 5 more. View the full customer network at chainsifter.com/chain/LFCR.

What sector is Lifecore Biomedical, Inc. in?

Lifecore Biomedical, Inc. (LFCR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Lifecore Biomedical, Inc. (LFCR) Suppliers & Customers

2Suppliers

10Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Lifecore Biomedical, Inc. (LFCR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

15Total relationships

2Distinct source URLs

4High confidence

0.705Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Lifecore Biomedical, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ALC	Alcon Inc.	72%	Reciprocal relationship from ALC graph: disasters, including climatic events (including any potential effect of climate change), power grid failures, acts of war or terrorism, workplace violence, pol…
SMNR	Semnur Pharmaceuticals, Inc.	62%	Reciprocal relationship from SMNR graph: ients’ willingness to pay out-of-pocket in the absence of such coverage and adequate reimbursement; and • our ability to compete with other treatments. We do …

Lifecore Biomedical, Inc. Customers

Ticker	Name	Confidence	Evidence
ALCON	ALCON	95%	Also in May 2023, we entered into an equipment sale and leaseback transaction with Alcon relating to equipment we use for manufacture of product for Alcon, as well as the Alcon Supply Agreement, and …
ALCON-RESEARCH-LLC	ALCON-RESEARCH-LLC	62%	r its investment in Windset under the fair value option. See Note 1 – Organization, Basis of Presentation, and Summary of Significant Accounting Policies for further information. On June 1, 2021, the…
COMPANY-CAMDEN-FRUIT-CORP	COMPANY-CAMDEN-FRUIT-CORP	62%	nts on long-term debt — ( 123,690 ) ( 86,411 ) Proceeds from revolving credit facility 149,586 31,450 55,111 Payments on revolving credit facility ( 146,704 ) ( 54,640 ) ( 44,111 ) Proceeds from exer…
CURATION-FOODS-INC	CURATION-FOODS-INC	62%	nts on long-term debt — ( 123,690 ) ( 86,411 ) Proceeds from revolving credit facility 149,586 31,450 55,111 Payments on revolving credit facility ( 146,704 ) ( 54,640 ) ( 44,111 ) Proceeds from exer…
FILO-AMENDMENT-LIMITED	FILO-AMENDMENT-LIMITED	62%	e of Contents a rate equal to 3% per annum in cash with the remainder payable-in-kind, in each case, unless otherwise elected by the Borrowers to pay a greater proportion in cash. The New Term Loan C…
NEWELL-CAPITAL-CORPORATION	NEWELL-CAPITAL-CORPORATION	62%	r its investment in Windset under the fair value option. See Note 1 – Organization, Basis of Presentation, and Summary of Significant Accounting Policies for further information. On June 1, 2021, the…
SIGNIFICANT-ACCOUNTING-POLICIES-ORGANIZATION-LIF	SIGNIFICANT-ACCOUNTING-POLICIES-ORGANIZATION-LIF	62%	nts on long-term debt — ( 123,690 ) ( 86,411 ) Proceeds from revolving credit facility 149,586 31,450 55,111 Payments on revolving credit facility ( 146,704 ) ( 54,640 ) ( 44,111 ) Proceeds from exer…
WYNNEFIELD-CAPITAL-INC	WYNNEFIELD-CAPITAL-INC	62%	r 1, 2023, and the payment of a $ 5.0 million working capital deposit to the Company. The working capital deposit was received on December 22, 2023 and (i) may be used for any corporate purpose; (ii)…
YUCATAN-ACQUISITION-HOLDINGS-LLC	YUCATAN-ACQUISITION-HOLDINGS-LLC	62%	nts on long-term debt — ( 123,690 ) ( 86,411 ) Proceeds from revolving credit facility 149,586 31,450 55,111 Payments on revolving credit facility ( 146,704 ) ( 54,640 ) ( 44,111 ) Proceeds from exer…
YUCATAN-FOODS-LLC	YUCATAN-FOODS-LLC	62%	nts on long-term debt — ( 123,690 ) ( 86,411 ) Proceeds from revolving credit facility 149,586 31,450 55,111 Payments on revolving credit facility ( 146,704 ) ( 54,640 ) ( 44,111 ) Proceeds from exer…

Lifecore Biomedical, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LFCR-DEBT	Debt stack $111.5M	90%	Market cache reports total debt of $111.5M.
LFCR-DEBT-10666	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-09-30.

Lifecore Biomedical, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Lifecore Biomedical, Inc..

Lifecore Biomedical, Inc. Ownership

Holder	Name	Confidence	Evidence
LFCR-OWNER-WYNNEFIELD-CAPITAL-INC	WYNNEFIELD CAPITAL INC	90%	13F overlay lists WYNNEFIELD CAPITAL INC as top holder; 107 tracked holders.

Lifecore Biomedical, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
STQN	Strategic Acquisitions, Inc.	100.00	2
BAX	Baxter International Inc.	100.00	2
COO	The Cooper Companies, Inc.	100.00	2
XRAY	DENTSPLY SIRONA Inc.	100.00	2
BHC	Bausch Health Companies Inc.	100.00	2
JNJ	Johnson & Johnson	100.00	2
EW	Edwards Lifesciences Corporation	100.00	2
SMNR	Semnur Pharmaceuticals, Inc.	100.00	1	['supplier']
STAA	STAAR Surgical Company	100.00	2
ALCON	ALCON	65.55	1	['receiving']
BSX	Boston Scientific Corporation	50.00	2
ORMP	Oramed Pharmaceuticals Inc.	50.00	2
MS-PE	Morgan Stanley	50.00	2
SCLX	Scilex Holding Company	50.00	2
SNYNF	Sanofi	50.00	2
YDES	YD Bio Ltd	50.00	2
SCLXW	Scilex Holding Co	50.00	2
OCS	Oculis Holding AG	50.00	2
SCILEX	SCILEX	50.00	2
ALC	Alcon Inc.	36.29	1	['supplier']

Lifecore Biomedical, Inc. Supply Chain